Colombia Authorizes Johnson & Johnson COVID-19 Vaccine for Emergency Use

Colombia has granted emergency use for the Johnson & Jonhson COVID-19 vaccine, the National Institute for Food and Drug Surveillance (Invima) announced on March 25.

“In its capacity as regulator, Invima has authorized the emergency use of the vaccine from the pharmaceutical company Janssen, of the multinational Johnson & Johnson,” Invima Director Julio Cesar Aldana announced during an evening broadcast.

Aldana also pointed out that the vaccine has less demanding storage requirements than the other vaccines.

The government has secured 9 million doses of the one-shot vaccine.

In a statement, Invima said the Specialized Chamber for New Molecules, New Indications, and Biological Medications of the Review Commission recommended the approval of the vaccine, making it the third COVID-19 vaccine in the country to receive the authorization.

Citing clinical studies carried out in several countries across the world, Invima stated that the vaccine was 66% effective against the disease.

Invima also said that the vaccine has also undergone clinical trials in the country, with over 5,800 voluntary participants.

According to data from Johns Hopkins University, Colombia has reported 2,359,942 cases and 62,519 deaths.


© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.